UBMD News

Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.

12/4/19

Twenty-five faculty members with a variety of clinical and research experience — representing eight medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.

12/4/19

Gabriela K. Popescu, PhD, professor of biochemistry, has been elected chair of the Council of Faculty and Academic Societies (CFAS) of the Association of American Medical Colleges (AAMC).

 

12/3/19

University at Buffalo researchers have launched a study that combines artificial intelligence (AI) with data gathered by continuous glucose monitoring devices.

12/2/19

Uninfected babies who are exposed to HIV and antiretroviral therapy in utero exhibit cardiac abnormalities early in life, suggesting that the drugs may put these babies at risk of adverse cardiac events.

 

11/21/19

According to Sanjay Sethi, MD, professor of medicine, the recent emergence of severe and even fatal vaping-related lung disease presents a challenge for health care providers and is causing some changes in their practices.

11/19/19

Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, received a rare, perfect score from the National Institutes of Health (NIH) on his grant application for expansion of a center designed to enhance care for older adults throughout Western New York.

11/18/19

From opium’s origins to the opioid epidemic, “Our Love Affair with Drugs” explores the eternal human quest to kill pain and attain new levels of consciousness.

11/13/19
There are two types of diabetes that affect children: Type 1 and Type 2. Watching for signs and symptoms is important for early detection and intervention. 
11/12/19

Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.